Challenges in Clinical Trial Design for Advanced NSCLC
Speaker: Federico Cappuzzo
- How is the molecular landscape of non-small-cell lung cancer (NSCLC) peculiar and how does it challenge the current concept of designing clinical trials?
- Considering the fast pace at which oncology is evolving, what other possible challenge could arise in the design of clinical trials?
- What is important to consider in designing the next generation of clinical trials for advanced NSCLC?